RLL, LLC
PrivateLast Round
Debt
Apr 6, 2026
Total Funding Raised
$2.72M
Company Overview
RLL, LLC is a biotechnology company that develops next-generation, low-toxicity therapeutics, including its lead candidate AOH1996, a first-in-class oral drug designed to selectively target cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RLL, LLC Comparables
Compare RLL, LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FoRx Therapeutics | 78% | |
| Artios Pharma | 77% | |
| Debiopharm Group | 67% | |
RLL, LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 6, 2026 | ||||
| Debt | Jun 24, 2025 | ||||
| VC Round | Jul 27, 2021 | ||||
| Seed | Feb 26, 2020 | ||||
| Debt | Apr 5, 2019 | ||||
Angel | Oct 9, 2018 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Raised $2M in a Seed Round.
- Jun 24, 2025
Completed a debt financing round.
RLL, LLC Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RLL, LLC's valuation, stock price, and market status.